These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 32317007
1. Can direct smear results that are routinely collected at health centre level be used for monitoring the impact of mass drug administration with praziquantel on schistosomiasis in Burundi? A preliminary assessment. Bizimana P, Polman K, Ortu G, Krit M, Nsabiyumva F, Nkeshimana A, Bijabuka U, Nibakire M, Van Geertruyden JP. Parasit Vectors; 2020 Apr 21; 13(1):206. PubMed ID: 32317007 [Abstract] [Full Text] [Related]
3. Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study. Okoyo C, Simiyu E, Njenga SM, Mwandawiro C. BMC Public Health; 2018 Apr 11; 18(1):478. PubMed ID: 29642875 [Abstract] [Full Text] [Related]
7. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial. Hoekstra PT, Casacuberta Partal M, Amoah AS, van Lieshout L, Corstjens PLAM, Tsonaka S, Assaré RK, Silué KD, Meité A, N'Goran EK, N'Gbesso YK, Roestenberg M, Knopp S, Utzinger J, Coulibaly JT, van Dam GJ. BMC Infect Dis; 2018 Dec 14; 18(1):662. PubMed ID: 30547750 [Abstract] [Full Text] [Related]
8. Capacity gaps in health facilities for case management of intestinal schistosomiasis and soil-transmitted helminthiasis in Burundi. Bizimana P, Polman K, Van Geertruyden JP, Nsabiyumva F, Ngenzebuhoro C, Muhimpundu E, Ortu G. Infect Dis Poverty; 2018 Jul 04; 7(1):66. PubMed ID: 29970181 [Abstract] [Full Text] [Related]
10. A comparative analysis of the cost-effectiveness of treatment based on parasitological and symptomatic screening for Schistosoma mansoni in Burundi. Carabin H, Guyatt H, Engels D. Trop Med Int Health; 2000 Mar 04; 5(3):192-202. PubMed ID: 10747282 [Abstract] [Full Text] [Related]
11. Mapping of Schistosoma mansoni in the Nile Delta, Egypt: Assessment of the prevalence by the circulating cathodic antigen urine assay. Haggag AA, Rabiee A, Abd Elaziz KM, Gabrielli AF, Abdel Hay R, Ramzy RMR. Acta Trop; 2017 Mar 04; 167():9-17. PubMed ID: 27965144 [Abstract] [Full Text] [Related]
12. Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study. Abudho BO, Ndombi EM, Guya B, Carter JM, Riner DK, Kittur N, Karanja DMS, Secor WE, Colley DG. Am J Trop Med Hyg; 2018 May 04; 98(5):1397-1402. PubMed ID: 29532768 [Abstract] [Full Text] [Related]
13. Prevalence of Schistosoma mansoni infection and the therapeutic efficacy of praziquantel among school children in Manna District, Jimma Zone, southwest Ethiopia. Bajiro M, Dana D, Ayana M, Emana D, Mekonnen Z, Zawdie B, Garbi A, Kure A, Zeynudin A. Parasit Vectors; 2016 Oct 24; 9(1):560. PubMed ID: 27772528 [Abstract] [Full Text] [Related]
14. Evaluating a point-of-care circulating cathodic antigen test (POC-CCA) to detect Schistosoma mansoni infections in a low endemic area in north-eastern Brazil. Bezerra FSM, Leal JKF, Sousa MS, Pinheiro MCC, Ramos AN, Silva-Moraes V, Katz N. Acta Trop; 2018 Jun 24; 182():264-270. PubMed ID: 29526480 [Abstract] [Full Text] [Related]
15. Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research. Colley DG, Fleming FM, Matendechero SH, Knopp S, Rollinson D, Utzinger J, Castleman JD, Kittur N, King CH, Campbell CH, Kabole FM, Kinung'hi S, Ramzy RMR, Binder S. Am J Trop Med Hyg; 2020 Jul 24; 103(1_Suppl):125-134. PubMed ID: 32400345 [Abstract] [Full Text] [Related]
17. Spatiotemporal distribution and population at risk of soil-transmitted helminth infections following an eight-year school-based deworming programme in Burundi, 2007-2014. Assoum M, Ortu G, Basáñez MG, Lau C, Clements ACA, Halton K, Fenwick A, Soares Magalhães RJ. Parasit Vectors; 2017 Nov 23; 10(1):583. PubMed ID: 29169386 [Abstract] [Full Text] [Related]
18. Anthelminthic treatment receipt and its predictors in Lake Victoria fishing communities, Uganda: Intervention coverage results from the LaVIISWA cluster randomised trial. Akurut H, Sanya RE, Lubyayi L, Nampijja M, Kizza M, Kaweesa J, Kizindo R, Sewankambo M, Nsubuga D, Tukahebwa E, Kabatereine NB, Elliott AM, Webb EL, LaVIISWA trial team. PLoS Negl Trop Dis; 2020 Oct 23; 14(10):e0008718. PubMed ID: 33075067 [Abstract] [Full Text] [Related]
19. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Stothard JR. Trans R Soc Trop Med Hyg; 2009 Apr 23; 103(4):325-32. PubMed ID: 19171359 [Abstract] [Full Text] [Related]
20. Mass drug administration with praziquantel reduces the prevalence of Schistosoma mansoni and improves liver morbidity in untreated preschool children. Cleland CR, Tukahebwa EM, Fenwick A, Blair L. Trans R Soc Trop Med Hyg; 2014 Sep 23; 108(9):575-81. PubMed ID: 25059523 [Abstract] [Full Text] [Related] Page: [Next] [New Search]